Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66e061087b8b0ca4bda35df8e395be73 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
filingDate |
2010-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8714968ac89cb9a3e66b354ba54af03c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a470080a1971b05f778073a839fe251a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d64e4ff1f26cdd11f92a63e45cc97c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90731be09786bccf219c667ec1b3518e |
publicationDate |
2010-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2010200752-A |
titleOfInvention |
Recombinant antibodies and immune complexes targeted to cells and tumors carrying CD22 |
abstract |
PROBLEM TO BE SOLVED: To provide a recombinant antibody and an immune complex targeted to cells and tumors having CD22, which have high affinity and cytotoxicity. And A recombinant immunoconjugate comprising a therapeutic agent or a detectable labeled peptide coupled to a recombinant anti-CD22 antibody having a VH containing cysteine at amino acid position 44 and a VL containing cysteine at amino acid position 100. By providing a body, the above problems have been solved. [Selection figure] None |
priorityDate |
1997-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |